- Report
- July 2025
- 150 Pages
South Africa
From €4374EUR$4,850USD£3,751GBP
- Report
- July 2025
- 150 Pages
Malaysia
From €4374EUR$4,850USD£3,751GBP
- Report
- July 2025
- 150 Pages
Italy
From €4374EUR$4,850USD£3,751GBP
- Report
- July 2025
- 150 Pages
Indonesia
From €4374EUR$4,850USD£3,751GBP
- Report
- March 2025
- 150 Pages
Global
From €4374EUR$4,850USD£3,751GBP
- Report
- July 2025
- 150 Pages
Turkey
From €4374EUR$4,850USD£3,751GBP
- Report
- May 2025
- 128 Pages
Global
From €4374EUR$4,850USD£3,751GBP
- Report
- April 2025
- 170 Pages
Global
From €4374EUR$4,850USD£3,751GBP
- Report
- February 2025
- 180 Pages
Global
From €4374EUR$4,850USD£3,751GBP
- Report
- April 2025
- 99 Pages
Global
From €3500EUR$4,157USD£3,106GBP
- Report
- March 2025
- 105 Pages
Global
From €3500EUR$4,157USD£3,106GBP
- Report
- March 2025
- 104 Pages
Global
From €3500EUR$4,157USD£3,106GBP
- Report
- February 2025
- 110 Pages
Global
From €3500EUR$4,157USD£3,106GBP
- Report
- January 2025
- 78 Pages
Global
From €3500EUR$4,157USD£3,106GBP
- Report
- May 2026
- 225 Pages
South Korea
From €4374EUR$4,850USD£3,751GBP
- Report
- May 2026
- 211 Pages
Australia
From €4374EUR$4,850USD£3,751GBP
- Report
- May 2026
- 212 Pages
Brazil
From €4374EUR$4,850USD£3,751GBP
- Report
- May 2026
- 213 Pages
Canada
From €4374EUR$4,850USD£3,751GBP
- Report
- May 2026
- 216 Pages
Indonesia
From €4374EUR$4,850USD£3,751GBP
- Report
- May 2026
- 217 Pages
Italy
From €4374EUR$4,850USD£3,751GBP

Biomedicine is a branch of biotechnology that focuses on the development of medical treatments and products. It involves the use of living organisms, such as bacteria, viruses, and cells, to create treatments and products that can be used to diagnose, prevent, and treat diseases. Biomedicine also includes the development of medical devices, such as prosthetics, and the use of genetic engineering to create new treatments.
Biomedicine is a rapidly growing field, with many companies investing in research and development. Companies in the biomedicine market are focused on developing treatments and products for a variety of diseases, including cancer, diabetes, and cardiovascular diseases. They are also working to develop treatments for rare diseases and to improve existing treatments.
Some of the companies in the biomedicine market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Celgene, Gilead Sciences, Johnson & Johnson, Merck, Novartis, Pfizer, and Roche. Show Less Read more